Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Sultamicillin, Atc J01cr04 For The Period 01.04.2026 - 31.03.2028 (plus Extension Option 1x12 Months) 2026-05-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Lercanidipine, Atc C08ca13 For The Period 01.04.2026 - 31.03.2028 (plus Extension Option 1x12 Months) 2026-05-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Estriol (excluding Dafo. Vcr) Atc G03cd01 For The Period 01.04.26 - 31.03.28 (plus Extension Option 1x12 Months) 2026-05-13
Germany Wheelchair Transport To Wfbm Eberbach (v9) 2026-05-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To Ss 130a Para. 8 Sgb V For The Active Ingredient Betamethasone + Gentamicin, Atc D07cc01 For The Period 01.04.26 - 31.03.28 (plus Extension Option 1x12 Months) 2026-05-13
Germany Open House Drug Discount Contracts For The Active Ingredient Palonosetron, Atc A04aa05 2026-05-13
Germany Conception And Implementation Of An Individual Measure Combination According To § 45 Sgb Iii For A Total Of Approximately 8 Participant Places In The District Of The Employment Agency Donauwörth. Individual Measure Combination, Participant Places 2026-05-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Ciclesonide, Atc R03ba08 For The Period 01.04.2026 - 31.03.2027 (plus Extension Option 1x12 Months) 2026-05-13
Germany 1/dlii4/vv098 - 1 Ea Mähraupe 2026-05-13
Germany Open House Drug Discount Contracts For The Active Ingredient Norethisterone And Estrogen, Atc G03fa01 2026-05-13
Whats app